It is worth noting that as an oncogene, MIAT can proliferate and migrate in various cancer cells such as hepatocellular carcinoma (Huang et al., 2018), osteosarcoma (Zhang et al., 2019), and papillary thyroid carcinoma (Wang et al., 2019b). This evidence concerns the gene MIAT and differentiated thyroid carcinoma.